Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 2/20 | 0.37 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KDM6B | O15054 | 2/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29960492 | 0.77 | MAP3K14 (0.41) | MAP3K14CA2OPRL1 | |
| SCHEMBL136087 | 0.71 | MAP3K14 (0.46) | MAP3K14CA2L3MBTL1OPRL1 | |
| SCHEMBL29960339 | 0.70 | — | — | |
| SCHEMBL29960441 | 0.70 | — | — | |
| SCHEMBL19829902 | 0.69 | MAP3K14 (0.45) | MAP3K14CA2OPRL1 | |
| SCHEMBL29960294 | 0.69 | — | — | |
| SCHEMBL9015271 | 0.68 | MAP3K14 (0.35) | MAP3K14OPRL1 | |
| SCHEMBL1804999 | 0.67 | ADRA2A (0.38) | P2RY6 | |
| SCHEMBL31607014 | 0.64 | PSMB5 (0.42) | — | |
| SCHEMBL29960243 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |